Daniel Glikman
Impact in
- Infectious Diseases top 10%
- Antimicrobial Resistance in Staphylococcus
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 17
- Pneumonia and Respiratory Infections 7
- Preterm Birth and Chorioamnionitis 2
-
- Antimicrobial Resistance in Staphylococcus 6
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Robert S. Daum (4 shared papers)Lea Even (1 shared paper)Irith Weissman (1 shared paper)Susan Boyle‐Vavra (2 shared papers)Michael David (2 shared papers)Ron Dagan (3 shared papers)Kamal Abu Jabal (6 shared papers)Amiel A. Dror (6 shared papers)
- Journals
- The Pediatric Infectious Disease Journal (6 papers)Acta Paediatrica (4 papers)American Journal of Obstetrics and Gynecology (3 papers)PEDIATRICS (3 papers)International Journal of Gynecology & Obstetrics (2 papers)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Daniel Glikman
51 papers receiving 736 citations
Peers
Comparison fields: 5 of 78
- Infectious Diseases 183
- Molecular Medicine 50
- Microbiology 60
- Epidemiology 265
- Drug Discovery 1
Countries citing papers authored by Daniel Glikman
This map shows the geographic impact of Daniel Glikman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Glikman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Glikman more than expected).
Fields of papers citing papers by Daniel Glikman
This network shows the impact of papers produced by Daniel Glikman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Glikman. The network helps show where Daniel Glikman may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Glikman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 97 | |
| 2 | 2022 | 97 | |
| 3 | 2008 | 72 | |
| 4 | 2012 | 60 | |
| 5 | 2006 | 52 | |
| 6 | 2007 | 28 | |
| 7 | 2010 | 24 | |
| 8 | 2009 | 21 | |
| 9 | 2015 | 18 | |
| 10 | 2020 | 17 | |
| 11 | 2017 | 17 | |
| 12 | 2005 | 16 | |
| 13 | 2019 | 15 | |
| 14 | 2006 | 15 | |
| 15 | 2010 | 14 | |
| 16 | 2018 | 13 | |
| 17 | 2015 | 13 | |
| 18 | 2020 | 12 | |
| 19 | 2016 | 12 | |
| 20 | 2021 | 12 |
About Daniel Glikman
Daniel Glikman is a scholar working on Epidemiology, Infectious Diseases, Public Health, Environmental and Occupational Health, Surgery and Neurology, having authored 59 papers that have together received 766 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (7 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Streptococcal Infections and Treatments (5 papers), Long-Term Effects of COVID-19 (5 papers), COVID-19 and Mental Health (4 papers), Neonatal and Maternal Infections (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Preterm Birth and Chorioamnionitis (2 papers). The work is most often cited by research in Infectious Diseases (183 citations), Molecular Medicine (50 citations), Microbiology (60 citations), Epidemiology (265 citations) and Drug Discovery (1 citation). Daniel Glikman has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Robert S. Daum, Lea Even, Irith Weissman, Susan Boyle‐Vavra, Michael David, Ron Dagan, Kamal Abu Jabal, Amiel A. Dror, Hiba Zayyad and Noga Givon‐Lavi. Their work appears in journals such as The Pediatric Infectious Disease Journal, Acta Paediatrica, American Journal of Obstetrics and Gynecology, PEDIATRICS and International Journal of Gynecology & Obstetrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.